The use of transfer factors in the treatment of multiple sclerosis: a case report.
A 23-year-old woman suffering from multiple sclerosis (MS) was given a course of 6 injections (0.5 U) of mumps transfer factor (TF) at 2-weekly intervals. The patient's symptoms improved dramatically and during the 10 months since treatment was instituted, no exacerbations have occurred. The possible aetiological role of paramyxoviruses in MS and the use of TF in the treatment of the disease are discussed. MS is however, a disease of exacerbations and spontaneous remissions, and despite our promising findings in this patient we wish to refrain from hailing mumps TF as a possible cure for this notorious disease.
D000328:Adult; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular; D009103:Multiple Sclerosis / Q000276:immunology / Q000628:therapy*; D009109:Mumps virus / Q000276:immunology; D012882:Skin Tests; D014165:Transfer Factor / Q000627:therapeutic use*
D014165:Transfer Factor